2026 Perinatal Substance Use Webinar Series

Substance-Exposed Infant and CPS Involvement

Every year, babies who have been exposed to substance in utero are born in Wisconsin. Knowing what to do can be a challenge. This presentation describes some of the basics of the Child Protective Service process—who needs to report, Wisconsin statutes relevant to substance exposure, the information that is needed, the hospital visit, and the range of initial determinations/actions.

Register to unlock the course, then click ‘Continue.’ Course materials are available at the bottom of this page.
Write your awesome label here.
Patrick Jones - Course author
Meet the instructorS

Laura Baker, MSW

Laura Baker has worked in child welfare for 18 years and has been employed with the Division of Milwaukee Child Protective Services for the past 15 years. She has worked as an Initial Assessment Supervisor for a unit specializing in substance-exposed infants and neonates and drug endangered children since 2015.


The speaker has no relevant financial relationships with ineligible companies.*

Patrick Jones - Course author

Lauren Borkenhagen, MSCP

Lauren Borkenhagen has been employed with the Division of Milwaukee Child Protective Services for close to 10 years and is currently an Initial Assessment Specialist Senior at the Division of Milwaukee Child Protective Services on the Drug Affected Infant and Unborn Child Abuse unit. She has worked in this capacity since 2019.

 

The speaker has no relevant financial relationships with ineligible companies.

Learning Outcomes

At the conclusion of this activity, participants will be able to:
  • Identify who needs to report
  • Describe what information is needed
  • Describe the initial determinations

Accreditation Statement

Continuing Medical Education

The Wisconsin Association for Perinatal Care (WAPC) is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. The Wisconsin Association for Perinatal Care (WAPC) designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. 

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee

No one in control of content has any relevant financial relationships with ineligible companies.*
*Ineligible companies are those whose primary business is producing, marketing, selling, reselling, or distributing health care products used by or on patients.

Course Information

This webinar was recorded on 22 January 2026.

The expiration date for this course is 22 January 2029.